Want to join the conversation?
$GALE said it is advancing GALE-401 (Anagrelide CR) into a late stage development for the treatment of essential thrombocythemia. $GALE plans to meet with FDA by end of year to discuss Phase 2/3 clinical trial design for GALE-401. $GALE expects to start pivotal trial in 1H17.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.